| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 |
| filingDate |
2004-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58002c2b160f412456c910df709fcba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58201b4f792b6794753e58a86879cdec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada674cd2dc8be05ff6e005e1bc442b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5914b0e5e3c66601a0ff30a3bf998ca2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0c69b0e5a0b7596f37371235c1b6c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baff5b6e9b45dba97111daeaba4a2e8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b5239a000b449d093c5c42ab8ef72e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2b683f017510fa1d6f95d9cdc35f395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2f20b668b9e09ea82c52fc8212a9803 |
| publicationDate |
2007-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7230007-B2 |
| titleOfInvention |
Derivatives of 3-(Guanidinocarbonyl) heterocycle, methods of preparation and intermediates thereof, their use as medicaments, and pharmaceutical compositions therefrom |
| abstract |
The present invention discloses and claims compounds of formula I n nand their pharmaceutically acceptable salts, and methods of using said compounds of formula I, either alone or in combination with other medicaments, as antiarrhythmic medicaments with a cardioprotective component for prophylaxis or treatment of infarction, for the treatment of angina pectoris, and as inhibitors of pathophysiological processes associated with the development of ischemia-induced damage, in particular in the triggering of ischemia-induced cardiac arrhythmias and of heart failure. Pharmaceutical compositions comprising compounds of formula I or compounds of formula I in combination with one or more other medicaments and processes for the preparation of compounds of formula I are also disclosed and claimed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11111264-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941175-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10407457-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9708359-B2 |
| priorityDate |
2003-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |